Vivos sees significant increase in HST
By HME News Staff
Updated 11:18 AM CST, Thu January 20, 2022
HIGHLANDS RANCH, Colo. – Vivos Therapeutics saw an 18-times increase in the total number of SleepImage Home Sleep Apnea Tests given across its network of trained dentists (known as Vivos Integrated Practices or VIPs) for the three months ended Dec. 31, 2021. The company also reported a 5.7-times increase in the number of VIPs administering HSTs; and a 3-times increase in the average number of HSTs being administered per VIP. “We have always believed that the pathway to getting more patients into treatment for OSA begins with an easy, inexpensive and highly accurate diagnostic process, which is precisely what the proprietary SleepImage test delivers,” said Kirk Huntsman, chairman and CEO of Vivos. “When coupled with the telemedicine model we have through our collaboration with Empower Sleep, which allows for the required medical diagnosis of OSA remotely, we believe that a historical barrier to patients obtaining a clear and medically valid sleep test report has now been eliminated.” As a result of the increase, Vivos has renegotiated its commercial agreement with SleepImage to lower costs and convert the entire diagnostic program. Under a new revenue model, Vivos will lease out the SleepImage ring recorders to Vivos trained dentists at a fixed price that includes a full month’s worth of diagnostic sleep test reports.
Comments